Over the past 10 years, the availability of pharmacologic quantities of hematopoietic growth factors has opened many avenues of study in basic science and clinical investigation. Pharmacologic agents that accelerate hematopoietic recovery obviously have the potential to improve selected therapeutic and supportive care aspects of cancer medicine. This article reviews important clinical and scientific aspects of hematopoietic growth factors, with an emphasis on their present-day use in the care of cancer patients.

Original languageEnglish (US)
Pages (from-to)165-184
Number of pages20
JournalCa-A Cancer Journal for Clinicians
Issue number3
StatePublished - 1996

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'Hematopoietic growth factors'. Together they form a unique fingerprint.

Cite this